These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 8678096
21. Effects of age and gender on pharmacokinetics of cefepime. Barbhaiya RH, Knupp CA, Pittman KA. Antimicrob Agents Chemother; 1992 Jun; 36(6):1181-5. PubMed ID: 1416818 [Abstract] [Full Text] [Related]
22. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion. Garrelts JC, Wagner DJ. Ann Pharmacother; 1999 Dec; 33(12):1258-61. PubMed ID: 10630824 [Abstract] [Full Text] [Related]
23. Cefepime: a new fourth-generation cephalosporin. Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA. Am J Hosp Pharm; 1994 Feb 15; 51(4):463-77; quiz 541-2. PubMed ID: 8017411 [Abstract] [Full Text] [Related]
24. Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits. Abd El-Aty AM, Goudah A, Mouneir SM, Sunwoo YE, Jang JH, Shin JG, Shim JH, Shimoda M. Vet Res Commun; 2007 Jan 15; 31(1):67-75. PubMed ID: 17186405 [Abstract] [Full Text] [Related]
25. Ocular penetration of cefepime following systemic administration in humans. Ozdamar A, Aras C, Ozturk R, Karacorlu M, Bahcecioglu H, Ozkan S. Ophthalmic Surg Lasers; 2001 Jan 15; 32(1):25-9. PubMed ID: 11195739 [Abstract] [Full Text] [Related]
26. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL. Clin Ther; 2005 May 15; 27(5):599-608. PubMed ID: 15978309 [Abstract] [Full Text] [Related]
33. Pharmacokinetics of cefepime in cystic fibrosis patients. Huls CE, Prince RA, Seilheimer DK, Bosso JA. Antimicrob Agents Chemother; 1993 Jul 15; 37(7):1414-6. PubMed ID: 8363368 [Abstract] [Full Text] [Related]
34. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses. Guglick MA, MacAllister CG, Clarke CR, Pollet R, Hague C, Clarke JM. Am J Vet Res; 1998 Apr 15; 59(4):458-63. PubMed ID: 9563631 [Abstract] [Full Text] [Related]
35. Pancreatic concentrations of cefepime in experimental necrotizing pancreatitis. Papagoras D, Giamarellos-Bourboulis EJ, Kanara M, Douridas G, Paraskevopoulos I, Antzaklis G, Karayannacos P, Giamarellou H. J Chemother; 2003 Feb 15; 15(1):43-6. PubMed ID: 12678413 [Abstract] [Full Text] [Related]
37. Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses. Barbhaiya RH, Forgue ST, Gleason CR, Knupp CA, Pittman KA, Weidler DJ, Martin RR. Antimicrob Agents Chemother; 1990 Jun 15; 34(6):1118-22. PubMed ID: 2203303 [Abstract] [Full Text] [Related]